Condensed Consolidated Statement of Changes in Stockholders’ Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income/(Loss)	Treasury Stock	Non-Controlling Interest
Beginning balance at Mar. 31, 2023	$ 73,302	$ 376	$ 218,473	$ (135,961)	$ (1,098)	$ (8,554)	$ 66
Beginning balance (in shares) at Mar. 31, 2023		37,621
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(6,171)		(2,902)	(3,269)
Net income attributable to non-controlling interest	6						6
Foreign currency translation adjustment	91				100		(9)
Issuance of restricted shares	0	$ 1	(1)
Issuance of restricted shares (in shares)		162
Shares withheld pursuant to vesting of restricted stock	(4)					(4)
Forfeiture of restricted shares (in shares)		(82)
Exercise of stock options (in shares)		16
Exercise of stock options	36		36
Stock-based compensation	852		852
Ending balance (in shares) at Jun. 30, 2023		37,717
Ending balance at Jun. 30, 2023	68,112	$ 377	216,458	(139,230)	(998)	(8,558)	63
Beginning balance at Mar. 31, 2023	73,302	$ 376	218,473	(135,961)	(1,098)	(8,554)	66
Beginning balance (in shares) at Mar. 31, 2023		37,621
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(19,190)
Net income attributable to non-controlling interest	38
Shares issued in connection with Combination	0
Ending balance (in shares) at Dec. 31, 2023		38,716
Ending balance at Dec. 31, 2023	57,644	$ 387	212,703	(146,281)	(616)	(8,651)	102
Beginning balance at Jun. 30, 2023	68,112	$ 377	216,458	(139,230)	(998)	(8,558)	63
Beginning balance (in shares) at Jun. 30, 2023		37,717
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(6,510)		(2,962)	(3,548)
Foreign currency translation adjustment	(906)				(906)
Issuance of restricted shares	0	$ 10	(10)
Issuance of restricted shares (in shares)		982
Shares withheld pursuant to vesting of restricted stock	(90)					(90)
Stock-based compensation	1,101		1,101
Ending balance (in shares) at Sep. 30, 2023		38,699
Ending balance at Sep. 30, 2023	61,707	$ 387	214,587	(142,778)	(1,904)	(8,648)	63
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(6,510)		(3,007)	(3,503)
Net income attributable to non-controlling interest	32						32
Foreign currency translation adjustment	1,295				1,288		7
Issuance of restricted shares	0	$ 2	(2)
Issuance of restricted shares (in shares)		28
Shares withheld pursuant to vesting of restricted stock	(3)					(3)
Forfeiture of restricted shares	0	$ (2)	2
Forfeiture of restricted shares (in shares)		(11)
Stock-based compensation	1,123		1,123
Ending balance (in shares) at Dec. 31, 2023		38,716
Ending balance at Dec. 31, 2023	57,644	$ 387	212,703	(146,281)	(616)	(8,651)	102
Beginning balance at Mar. 31, 2024	$ 38,636	$ 387	202,607	(154,796)	(985)	(8,682)	105
Beginning balance (in shares) at Mar. 31, 2024	37,212	38,709
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	$ (22,337)		(25)	(22,312)
Net income attributable to non-controlling interest	13						13
Foreign currency translation adjustment	426				418		8
Issuance of restricted shares	0	$ 1	(1)
Issuance of restricted shares (in shares)		54
Shares issued for transaction bonus	889	$ 1	888
Shares issued for transaction bonus (in shares)		174
Shares issued in connection with Combination	362,005	$ 707	361,298
Shares issued in connection with Combination (in shares)		70,704
Acquired through MiX Combination	7,823		7,818				5
Shares withheld pursuant to vesting of restricted stock	(2,836)					(2,836)
Stock-based compensation	5,929		5,929
Ending balance (in shares) at Jun. 30, 2024		109,641
Ending balance at Jun. 30, 2024	390,548	$ 1,096	578,514	(177,108)	(567)	(11,518)	131
Beginning balance at Mar. 31, 2024	$ 38,636	$ 387	202,607	(154,796)	(985)	(8,682)	105
Beginning balance (in shares) at Mar. 31, 2024	37,212	38,709
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	$ (38,573)
Net income attributable to non-controlling interest	17
Shares issued in connection with Combination	$ 362,005
Ending balance (in shares) at Dec. 31, 2024	132,493	134,556
Ending balance at Dec. 31, 2024	$ 458,541	$ 1,339	669,492	(193,345)	(7,578)	(11,518)	151
Beginning balance at Jun. 30, 2024	390,548	$ 1,096	578,514	(177,108)	(567)	(11,518)	131
Beginning balance (in shares) at Jun. 30, 2024		109,641
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(1,888)			(1,888)
Net income attributable to non-controlling interest	5						5
Foreign currency translation adjustment	(777)				(797)		20
Proceeds from private placement, net of costs to issue common stock	61,851		61,851
Exercise of stock options (in shares)		243
Stock-based compensation	1,371		1,371
Ending balance (in shares) at Sep. 30, 2024		109,884
Ending balance at Sep. 30, 2024	451,110	$ 1,096	641,736	(178,996)	(1,364)	(11,518)	156
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(14,349)			(14,349)
Net income attributable to non-controlling interest	(1)						(1)
Foreign currency translation adjustment	(6,218)				(6,214)		(4)
Shares issued in connection with Combination	21,343	$ 43	21,300
Shares issued in connection with Combination (in shares)		4,286
Proceeds from private placement, net of costs to issue common stock (in shares)		20,000
Proceeds from private placement, net of costs to issue common stock	4,608	$ 200	4,408
Exercise of stock options (in shares)		161
Exercise of stock options	910		910
Stock-based compensation	$ 1,138		1,138
Issue of stock appreciation rights (in shares)		225
Ending balance (in shares) at Dec. 31, 2024	132,493	134,556
Ending balance at Dec. 31, 2024	$ 458,541	$ 1,339	$ 669,492	$ (193,345)	$ (7,578)	$ (11,518)	$ 151